Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.

  title={Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.},
  author={Ariel Roguin and Chandra S Bomma and Khurram Nasir and Harikrishna S. Tandri and Crystal Tichnell and Cynthia H. James and Julie Rutberg and J Brent Crosson and Philip J. Spevak and Ronald D. Berger and Henry R. Halperin and Hugh Calkins},
  journal={Journal of the American College of Cardiology},
  volume={43 10},
OBJECTIVES The aim of this study was to assess the outcome of arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) patients treated with an implantable cardioverter-defibrillator (ICD). BACKGROUND Arrhythmogenic right ventricular dysplasia/cardiomyopathy is associated with tachyarrhythmia and an increased risk of sudden death. METHODS This study included 42 ARVD/C patients with ICDs (52% male, age 6 to 69 years, median 37 years) followed at our center. RESULTS Mean follow-up… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 84 extracted citations


Publications referenced by this paper.
Showing 1-10 of 32 references

Long - term results of cardioverterdefibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias

  • R Tavernier, S Gevaert, J DeSutter
  • Heart
  • 2001

Similar Papers

Loading similar papers…